We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Atomic Force Microscopy Differentiates Cancerous from Normal Cells

By LabMedica International staff writers
Posted on 29 Apr 2009
Using an atomic force microscope, scientists discovered that cancer cells and normal cells had different cell surface properties. More...
The difference in the brush layers covering the cell surface might have a biological significance, and could be used for detection of cancer.

Brushes on the cell surface, mostly consisting of microridges and tiny hairs called microvilli, are important for interacting with the external environment. The investigators processed force measurements--taken from the cell surface using an atomic force microscope--according to a model that accounts for these brushes, to quantitatively show that cancerous cells are different. Normal cells have brushes of one length, whereas cancerous cells have mostly two brush lengths of significantly different densities.

The scientific group was led by Igor Sokolov, director of the Nanoengineering and Biotechnology Laboratories Center at Clarkson University (Potsdam, NY, USA). "Cancer cells are traditionally detected by biochemical means," said Professor Sokolov. "However, despite many years of success, those methods have not resulted in defeating cancer. Therefore, it is very important to search for alternative, nontraditional ways of looking at cancer. Investigation of the physical properties of cell surfaces might be one such nontraditional way."

The authors also demonstrated that the difference found in cell surface "brush" is practically impossible to find with other microscopic methods.

The study appeared online in Nature Nanotechnology, on April 13, 2009.

Related Links:

Clarkson University



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.